Lipoprotein lipase links vitamin D, insulin resistance, and type 2 diabetes: A cross-sectional epidemiological study

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  Huang, Yifan ^a   Li, Xiaoxia ^a   Wang, Maoqing ^a   Ning, Hua ^a   A, Lima ^a   Li, Ying ^a   Sun, Changhao ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Insulin resistance; Lipid metabolism; Lipoprotein lipase; Vitamin D

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; FATTY ACID; LIPOPROTEIN LIPASE; VITAMIN D;

ADULT; ARTICLE; CHINA; CHINESE; CONCENTRATION (PARAMETERS); FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; VITAMIN BLOOD LEVEL;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; VITAMIN D; YOUNG ADULT;

EID: 84873638923     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-17     Document Type: Article

References (37)

1. Hide WA, Chan L, Li WH. Structure and evolution of the lipase superfamily. Journal of lipid research 1992, 33(2):167-178.
2. Mead JR, Irvine SA, Ramji DP. Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med (Berl) 2002, 80(12):753-769.
3. Goldberg IJ, Merkel M. Lipoprotein lipase: physiology, biochemistry, and molecular biology. Frontiers in bioscience: a journal and virtual library 2001, 6:D388-D405.
4. Hanyu O, Miida T, Kosuge K, Ito T, Soda S, Hirayama S, Wardaningsih E, Fueki Y, Obayashi K, Aizawa Y. Preheparin lipoprotein lipase mass is a practical marker of insulin resistance in ambulatory type 2 diabetic patients treated with oral hypoglycemic agents. Clinica chimica acta; international journal of clinical chemistry 2007, 384(1-2):118-123.
5. Eckel RH, Yost TJ, Jensen DR. Alterations in lipoprotein lipase in insulin resistance. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity 1995, 19(Suppl 1):S16-S21.
6. Eriksson JW, Buren J, Svensson M, Olivecrona T, Olivecrona G. Postprandial regulation of blood lipids and adipose tissue lipoprotein lipase in type 2 diabetes patients and healthy control subjects. Atherosclerosis 2003, 166(2):359-367.
7. Taskinen MR. Lipoprotein lipase in diabetes. Diabetes/metabolism reviews 1987, 3(2):551-570.
8. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007, 26(5):573-580.
9. Lu L, Yu Z, Pan A, Hu FB, Franco OH, Li H, Li X, Yang X, Chen Y, Lin X. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes care 2009, 32(7):1278-1283.
10. Delvin EE, Lambert M, Levy E, O'Loughlin J, Mark S, Gray-Donald K, Paradis G. Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. The Journal of nutrition 2010, 140(5):987-991.
11. Vu D, Ong JM, Clemens TL, Kern PA. 1,25-dihydroxyvitamin D induces lipoprotein lipase expression in 3 T3-L1 cells in association with adipocyte differentiation. Endocrinology 1996, 137(5):1540-1544.
12. Huang L, Xue J, He Y, Wang J, Sun C, Feng R, Teng J, He Y, Li Y. Dietary calcium but not elemental calcium from supplements is associated with body composition and obesity in Chinese women. PloS one 2011, 6(12):e27703.
13. Trumbo P, Schlicker S, Yates AA, Poos M. Food, Nutrition Board of the Institute of Medicine TNA: Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. Journal of the American Dietetic Association 2002, 102(11):1621-1630.
14. World Health Organization International Diabetes Federation 2006, World Health Organization: Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Geneva, World Health Organization.
15. Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT, Petruschke RA, Chen E, de Papp AE. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. The Journal of clinical endocrinology and metabolism 2005, 90(6):3215-3224.
16. Ujcic-Voortman JK, Schram MT, der Bruggen MA J-V, Verhoeff AP, Baan CA. Diabetes prevalence and risk factors among ethnic minorities. European journal of public health 2009, 19(5):511-515.
17. Hanefeld M, Koehler C, Gallo S, Benke I, Ott P. Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovascular diabetology 2007, 6:13.
18. Liu S, Wang W, Zhang J, He Y, Yao C, Zeng Z, Piao J, Howard BV, Fabsitz RR, Best L, et al. Prevalence of diabetes and impaired fasting glucose in Chinese adults, China National Nutrition and Health Survey, 2002. Preventing chronic disease 2011, 8(1):A13.
19. Feng RN, Zhao C, Wang C, Niu YC, Li K, Guo FC, Li ST, Sun CH, Li Y. BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults. Journal of epidemiology/ Japan Epidemiological Association 2012, 22(4):317-323.
20. Holick MF. Vitamin D deficiency. N Engl J Med 2007, 357(3):266-281.
21. Hypponen E, Boucher BJ, Berry DJ, Power C. 25-Hydroxyvitamin D, IGF-1, and Metabolic Syndrome at 45 Years of Age: A Cross-Sectional Study in the 1958 British Birth Cohort. Diabetes 2007, 57(2):298-305.
22. Ford ES, Zhao G, Li C, Pearson WS. Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States. Journal of diabetes 2009, 1(4):296-303.
23. Ford ES, Ajani UA, McGuire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes care 2005, 28(5):1228-1230.
24. Hjelmesaeth J, Hofso D, Aasheim ET, Jenssen T, Moan J, Hager H, Roislien J, Bollerslev J. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study. Cardiovascular diabetology 2009, 8:7.
25. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. The Journal of clinical endocrinology and metabolism. 2007, 92(6):2017-2029.
26. Salum E, Kampus P, Zilmer M, Eha J, Butlin M, Avolio AP, Podramagi T, Arend A, Aunapuu M, Kals J. Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes. Cardiovascular diabetology 2012, 11:58.
27. Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP. Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study. Cardiovascular diabetology 2012, 11(1):85.
28. Makoveichuk E, Sukonina V, Kroupa O, Thulin P, Ehrenborg E, Olivecrona T, Olivecrona G. Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed. Biochem Biophys Res Commun 2012, 425(2):138-143.
29. Mingrone G, Henriksen FL, Greco AV, Krogh LN, Capristo E, Gastaldelli A, Castagneto M, Ferrannini E, Gasbarrini G, Beck-Nielsen H. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes 1999, 48(6):1258-1263.
30. Braun JE, Severson DL. Regulation of the synthesis, processing and translocation of lipoprotein lipase. The Biochemical journal 1992, 287(Pt 2):337-347.
31. Querfeld U, Hoffmann MM, Klaus G, Eifinger F, Ackerschott M, Michalk D, Kern PA. Antagonistic effects of vitamin D and parathyroid hormone on lipoprotein lipase in cultured adipocytes. J Am Soc Nephrol 1999, 10(10):2158-2164.
32. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005, 48(7):1247-1257.
33. Riserus U, Sprecher D, Johnson T, Olson E, Hirschberg S, Liu A, Fang Z, Hegde P, Richards D, Sarov-Blat L, et al. Activation of peroxisome proliferator-activated receptor (PPAR)delta promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatty acid oxidation in moderately obese men. Diabetes 2008, 57(2):332-339.
34. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr 2002, 21(2):146S-151S.
35. He YH, Song Y, Liao XL, Wang L, Li G, Alima LG, Li Y, Sun CH. The calcium-sensing receptor affects fat accumulation via effects on antilipolytic pathways in adipose tissue of rats fed low-calcium diets. The Journal of nutrition 2011, 141(11):1938-1946.
36. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81(3):353-373.
37. Yan L, Prentice A, Zhang H, Wang X, Stirling DM, Golden MM. Vitamin D status and parathyroid hormone concentrations in Chinese women and men from north-east of the People's Republic of China. European journal of clinical nutrition 2000, 54(1):68-72.